No Pharma Money
En Español

Drugs Don’t Work If People Can’t Afford Them

Our vision is simple

Every person in the United States can get the prescription drugs they need at prices they can afford.

For too long, drug companies have shaped the system in their favor while patients pay the price.

We empower and mobilize patients and allies, hold accountable those in power, and fight to shape and achieve system-changing policies that make prescription drugs affordable for all. We are independent, bipartisan, and do not accept contributions from any organization that profits from the development or distribution of prescription drugs.

Learn More
Current Campaign · The ETHIC Act

Take action now

Help build support for the bipartisan ETHIC Act, which would help bring lower-cost generic medicines to patients sooner.

Write Your Representative
Jackie Trapp, a multiple myeloma patient from Muskego, Wisconsin

“My out-of-pocket drug costs for my multiple myeloma treatment could be as much as $21,000 a year. My energy to fight my cancer was diverted to finding ways to pay for my prescriptions.”

Jackie Trapp Muskego, Wisconsin

Millions of Americans struggle to afford the medications they need. We organize patients to change the policies that keep prices high.

Add Your Voice Share Your Story The most powerful advocates are the people living with the consequences of high prices every day. Your experience can help drive the fight for lower drug prices. Share Your Story
Our Impact

When patients organize, change happens

$2,000

Since 2025, for the first time, there's an annual cap on Medicare prescription drug costs

$35
Monthly insulin cap

Patients on Medicare pay no more than $35 a month for insulin since 2023.

1st
Drug price negotiation

The first negotiated prices under Medicare took effect in 2026.

$0
Free recommended vaccines

Recommended vaccines are free for patients on Medicare since 2023.

Stay Updated

News & Reports

All News
Latest News Nov 18, 2026

ICYMI: P4ADNow CEO Testifies Before Senate Judiciary Committee, Urges Congress To Advance Bipartisan Drug Price Reforms Before Year-End

WASHINGTON, D.C. — Yesterday, Patients For Affordable Drugs Now CEO Merith Basey testified before the Senate Judiciary Committee, urging Congress to advance bipartisan legislation before the end of the year to curb pharmaceutical industry abuses of the patent system, increase competition, and lower prescription drug prices for patients and taxpayers. Throughout the hearing, senators from […]

Read Article
Latest News Nov 18, 2026

“The choice is not between innovation and affordability. Patients need both.”

P4ADNow CEO Testifies Before Senate Judiciary Committee, Urges Congress To Advance Bipartisan Drug Price Reforms Before Year-End P4AD CEO Merith Basey’s Opening Testimony: Merith highlighted how patent abuses delay competition and keep prices high for American patients. She shared the experiences of patient advocate Kevin Baker and P4ADNow founder David Mitchell to underscore why patients […]

Read Article
Latest News Nov 16, 2026

P4ADNow CEO to Urge Congress To Advance Bipartisan Reforms Targeting Big Pharma’s Patent Abuse During Testimony Before Senate Judiciary Committee

Merith Basey will bring patients’ stories to Capitol Hill as lawmakers examine how pharmaceutical companies block competition and keep drug prices high.  WASHINGTON, D.C. — Tomorrow, Patients For Affordable Drugs Now CEO Merith Basey will testify before the Senate Judiciary Committee at its hearing, “Prescribing Sunshine: How Competition & Transparency Lowers Prescription Drug Costs.” Basey […]

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.